Clinical Trials
3 trialsNCT05986318 2026-03-09
RESPIRE-ILD
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Phase 2 Recruiting
NCT02908750 2022-11-14
Study to Assess the Effect of Osimertinib (TAGRISSOâ„¢ ) on Blood Levels of Fexofenadine in Patients With EGFRm+ NSCLC
AstraZeneca
Phase 1 Completed
NCT02476526 2017-11-28
Safety of Low Dose IV Contrast CT Scanning in Chronic Kidney Disease
VA Greater Los Angeles Healthcare System
Phase 4 Completed